History of the University of Illinois Urbana-Champaign

The American College of Veterinary Internal Medicine Announces 2023 Recognition Awards

Retrieved on: 
Tuesday, July 11, 2023
Education, Health, Consumer, Pets, University, Veterinary, Lee, Critical care, University of Minnesota College of Pharmacy, College, Emergency, University college, History of the University of Illinois Urbana-Champaign, Associate, Auburn University College of Architecture, Design, and Construction, Journal of Veterinary Internal Medicine, Animal, Cardiology, Internal medicine, ISCB Senior Scientist Award, Virginia–Maryland College of Veterinary Medicine, American College, Iowa State University College of Veterinary Medicine, Veterinary medicine, Auburn University, Dentistry, Nursing

The American College of Veterinary Internal Medicine (ACVIM) is pleased to announce the recipients of the 2023 ACVIM Recognition Awards.

Key Points: 
  • The American College of Veterinary Internal Medicine (ACVIM) is pleased to announce the recipients of the 2023 ACVIM Recognition Awards.
  • These accomplished veterinary professionals have demonstrated excellence, dedicated service and expertise, making a significant impact on the wellbeing of animals and advancing the veterinary profession.
  • The awards were presented during the 2023 ACVIM Forum in Philadelphia, Pennsylvania, before an international audience of ACVIM Diplomates and veterinary professionals.
  • The award winners are:
    Dr. Peter Constable, Dean of the College of Veterinary Medicine at the University of Illinois Urbana-Champaign, is the 2023 recipient of the Robert W. Kirk Award for Professional Excellence for his outstanding career and lifetime of contributions to the ACVIM and veterinary internal medicine.

Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation

Retrieved on: 
Wednesday, February 8, 2023
Harvard University, Yale School of Medicine, MIT, Machine learning, MBA, History of the University of Illinois Urbana-Champaign, Synthetic biology, Adaptive immune system, Biotechnology, Electrical engineering, Drug design, SAB, Drug, Computer science, Therapy, Massachusetts Institute of Technology, Harvard Medical School, United States Air Force Scientific Advisory Board, ETH, University, Patient, Broad Institute, Sai, Translational medicine, SVP, Biological engineering, Probability, University of Oslo, Associate, Executive, University of Mainz, Doctor of Philosophy, Research, Medical device, AI, MD

VANCOUVER, Wash. and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the expansion of its Scientific Advisory Board with three world-class scientific leaders: Victor Greiff, Ph.D., Timothy Lu, MD, Ph.D., and Hubert Truebel, MD, Ph.D., MBA.

Key Points: 
  • VANCOUVER, Wash. and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the expansion of its Scientific Advisory Board with three world-class scientific leaders: Victor Greiff, Ph.D., Timothy Lu, MD, Ph.D., and Hubert Truebel, MD, Ph.D., MBA.
  • These renowned leaders in AI drug design, synthetic biology, and translational medicine, respectively, will play a pivotal role in helping Absci continue to pioneer AI drug creation in its mission to create better biologics for patients, faster.
  • “In silico drug design requires vast amounts of high-quality wet lab datasets to effectively build and train generative AI models.
  • “Absci is harnessing generative AI to pioneer the next frontier of antibody drug discovery to deliver better drugs to patients faster,” said Dr. Lu.